Reduced the levels of α-SMA, HYP, collagen type I/III, IL-6, TGF-β1, NOX4; increase the levels of SOD and GSH; increased body weight, survival rate, and alleviated alveolar structure, alveolar inflammation, and the degree of PF. The gene discussed is ACTA1; the disease is pemphigus foliaceus.